Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


5 Value Stocks To Watch In The Healthcare Sector


Benzinga | Aug 30, 2021 10:22AM EDT

5 Value Stocks To Watch In The Healthcare Sector

What are Value Stocks?

A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.

Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:

2 Innoviva (NASDAQ:INVA) - P/E: 5.92

4 Relay Therapeutics (NASDAQ:RLAY) - P/E: 7.34

6 Collegium Pharmaceutical (NASDAQ:COLL) - P/E: 7.5

8 Timber Pharmaceuticals (AMEX:TMBR) - P/E: 0.9

10 Voyager Therapeutics (NASDAQ:VYGR) - P/E: 6.29

Most recently, Innoviva reported earnings per share at 0.9, whereas in Q1 earnings per share sat at 0.84. Innoviva does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

This quarter, Relay Therapeutics experienced a decrease in earnings per share, which was -0.47 in Q1 and is now -0.64. Relay Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Most recently, Collegium Pharmaceutical reported earnings per share at 0.27, whereas in Q1 earnings per share sat at 0.41. Collegium Pharmaceutical does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Timber Pharmaceuticals has reported Q2 earnings per share at -0.08, which has decreased by 60.0% compared to Q1, which was -0.05. Timber Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Voyager Therapeutics's earnings per share for Q2 sits at -0.8, whereas in Q1, they were at -0.58. Voyager Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC